1. |
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis [J]. Cell, 1990; 61(5)∶759.
|
2. |
Matsuda S, KawamuraTsuzuku J, Ohsugi M, et al. Tob, a novel protein that interacts with p185erbB2, is associated with antiproliferative activity [J]. Oncogene, 1996; 12(4)∶705.
|
3. |
Iwanaga K, Sueoka N, Sato A, et al. Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer [J]. Cancer Lett, 2003; 202(1)∶71.
|
4. |
來茂德. 中國結直腸癌發生發展相關基因 [J]. 世界華人消化雜志, 2001; 9(11)∶1227.
|
5. |
Matsuda S, Rouault J, Magaud J, et al. In search of a function for the TIS21/PC3/BTG1/TOB family [J]. FEBS Lett, 2001; 497(2-3)∶67.
|
6. |
Fong KM, Kida Y, Zimmerman PV, et al. Loss of heterozygosity frequently affects chromosome 17q in nonsmall cell lung cancer [J]. Cancer Res, 1995; 55(19)∶4268.
|
7. |
Yoshida Y, Nakamura T, Komoda M, et al. Mice lacking a transcriptional corepressor Tob are predisposed to cancer [J]. Genes Dev, 2003; 17(10)∶1201.
|
8. |
Ahn SH, Sawada H, Ro JY, et al. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues [J]. Clin Exp Metastasis, 1997; 15(2)∶151.
|
9. |
Masaki T, Tokuda M, Ohnishi M, et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma [J]. Hepatology, 1996; 24(1)∶72.
|
10. |
Xia SH, Hu LP, Hu H, et al. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but downregulated in esophageal squamous cell carcinomas [J]. Oncogene, 2002; 21(43)∶6641.
|
11. |
Paweletz CP, Ornstein DK, Roth MJ, et al. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma [J]. Cancer Res, 2000; 60(22)∶6293.
|
12. |
Roninson IB. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumourpromoting activities of stromal fibroblasts [J]. Cancer Lett, 2002; 179(1)∶1.
|